School of Medicine
Showing 251-300 of 1,319 Results
-
Parnika Prashasti Saxena
Clinical Professor, Psychiatry and Behavioral Sciences
BioParnika Saxena is board certified in general and geriatric psychiatry. She completed her residency at St Elizabeth's Medical Center (affiliated with Tufts University School of Medicine) in Massachusetts and a clinical geriatric fellowship at the University of California, Los Angeles. She also worked as a research fellow in Clinical Psychopharmacology at Mclean Hospital (affiliated with Harvard Medical School) and also completed a psychoanalytic psychotherapy fellowship from the Boston Psychoanalytic Society and Institute. Her primary research interests lie in pharmacological and interventional treatments for resistant depression. At Stanford, she works on the inpatient service, outpatient geropsychiatry clinic and the electroconvulsive therapy service. She also serves at the program director of the Geriatric Psychiatry Fellowship. In addition to her clinical and research interests, she is passionate about patient advocacy and promoting mental health legislative changes to benefit patient care and has testified in state senate hearings to that end as a physician representative of organizations like the Northern California Psychiatric Association and American Psychiatric Association.
-
Nazish Sayed MD, PhD
Associate Professor (Research) of Surgery (Vascular Surgery)
Current Research and Scholarly InterestsThe Sayed Laboratory investigates how endothelial dysfunction contributes to cardiovascular disease and leverages human stem cell technologies to identify novel therapeutic strategies. Our research integrates patient-derived induced pluripotent stem cells (iPSCs), engineered cardiac tissues, organoids, human biospecimens, and multi-omic technologies to uncover mechanisms underlying inherited and acquired cardiovascular diseases.
A major focus of the laboratory is understanding endothelial–cardiomyocyte communication in cardiomyopathy. Using patient-specific iPSCs, human cardiac organoids, engineered heart tissues, spatial transcriptomics, and single-cell multi-omics, we study how endothelial dysfunction drives myocardial fibrosis, inflammation, and heart failure. Current efforts include investigations into LMNA-related dilated cardiomyopathy, endothelial-to-mesenchymal transition (EndoMT), and mechanisms of fibrotic remodeling.
A second major area of research is cardio-oncology. The laboratory develops human disease models to understand cardiovascular complications associated with cancer therapies, including tyrosine kinase inhibitors and immune checkpoint inhibitors. These studies have identified novel vascular mechanisms underlying treatment-related hypertension, cardiomyopathy, and heart failure.
The laboratory also investigates cardiovascular aging, toxic environmental exposures, rare vascular diseases, and regenerative medicine. By integrating human tissues, advanced stem cell models, genome engineering, spatial biology, and artificial intelligence–enabled multi-omic analyses, our goal is to develop precision therapeutic strategies that improve cardiovascular health and patient outcomes. -
Michael Scahill
Clinical Assistant Professor, Pediatrics - Neonatology
BioOn a trip to Mozambique while in med school here at Stanford, Dr Scahill saw the power of market interventions to transform healthcare. This led to his current focus on technology, data & AI. A veteran data scientist, his research trawls the oceans of data each patient generates for patterns to predict dangerous outcomes before they happen in Stanford's top level NICU, where he also still serves as a frontline clinician. Outside Stanford, he is the digital lead at Valley Children's hospital and advises health technology startups in Silicon Valley and beyond.
-
John Scandling
Professor of Medicine (Nephrology) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsTolerance induction in clinical kidney transplantation
-
Blake K. Scanlon, Ph.D.
Adjunct Lecturer, Psych/Public Mental Health & Population Sciences
BioThe overarching aim of Dr. Scanlon’s research is to develop and evaluate low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. To that end, the Caregiver Technology Division of the Scanlon Lab aims to enhance patient- and family-centered care through novel, broadly customizable, and highly scalable caregiver interventions. In parallel, the Neurodegenerative Division of the Scanlon Lab focuses on the development and application of cognitive, neuropsychiatric, and biological markers for the initiation and progression of neurodegeneration.
Dr. Scanlon received his bachelor’s degree in Neuroscience and doctorate in Clinical Health Psychology from the University of Miami. After concluding his clinical internship in Geropsychology/Neuropsychology at the VA Palo Alto Health Care System (VAPAHCS), he completed fellowships in Aging and Dementia at Stanford University School of Medicine and VAPAHCS. Dr. Scanlon is currently a VA Career Development Awardee in the Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC) and Stanford/VA Aging Clinical Research Center where his work focuses on developing and evaluating low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. He also serves as Co-Director of the Stanford/VA California Alzheimer's Disease Center, Chair of the VAPAHCS Dementia Committee, and Co-Chair of the Department of Veterans Affairs VISN 21 Dementia Committee. -
Lidia Schapira
Professor of Medicine (Oncology)
BioDr. Schapira is a medical oncologist with clinical expertise in the treatment of breast cancer. As the inaugural Director of Stanford's Cancer Survivorship Program, she has developed a thriving research and clinical program focused on optimizing health outcomes for people living with and beyond cancer. Dr. Schapira is interested in training future generations of physician-scientists as well as the broader community of practicing physicians through the design of innovative educational programs. Dr. Schapira's advocacy for people with cancer led to her appointment as Editor-in-Chief of the American Society of Clinical Oncology's website for the public,Cancer.Net, a position she held from 2015 until-2021. She served on the Board of Directors of the American Psychosocial Oncology Society and as Chair of the Psychosocial Interest Group of the Multinational Society for Supportive Care in Cancer. Dr. Schapira is particularily committed to reducing inequities in cancer outcomes and improve access to cancer care and cancer clinical trials. Dr. Schapira has published numerous manuscripts, lectures both nationally and internationally on issues of cancer survivorship and served as Associate Editor of the narrative section, Art of Oncology, for the Journal of Clinical Oncology from 2013 until 2023.
-
Salena Schapp
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Salena Schapp is a licensed psychologist (PSY29619) and Co-Founder of Beyond Measure. She has experience treating patients across the lifespan, and a particular specialty working with children, adolescents, and families. In her work with children and families, Dr. Schapp is collaborative, compassionate, and playful. She provides a range of psychological services, specializing in treatment of eating disorders, anxiety, behavioral challenges, and trauma. Dr. Schapp is passionate about helping families create a supportive and strong parent-child relationship. She uses evidenced-based approaches to therapy, while individualizing treatment to match each patient’s needs, including cognitive behavioral therapy, family-based therapy, parent management training, parent-child interaction therapy, acceptance and commitment therapy, and dialectical behavioral therapy. She practices from a weight-inclusive, Health at Every Size (HAES)® approach, to help individuals improve their relationship to food and their bodies. Dr. Schapp also has extensive experience with group therapy, and enjoys creating a supportive, safe, and helpful group environment. She is an Adjunct Clinical Assistant Professor for the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine, where she runs a support group for psychiatry residents.
Dr. Schapp completed her graduate training in clinical psychology at the PGSP-Stanford PsyD Consortium, where she focused her studies on children and families. She finished her predoctoral internship training at University of Texas Austin/Dell Children’s Medical Center and her postdoctoral residency at Kaiser Permanente in Redwood City. Dr. Schapp enjoys giving back to the psychological community, and currently serves as the President of the SF Bay Area Chapter of the International Association for Eating Disorder Professionals. She has a strong interest in teaching and supervision, and has provided training opportunities and supervision for trainees at Kaiser Permanente and Beyond Measure. She also enjoys consulting with and teaching other professionals and the community at large through trainings and presentations. -
Alan F. Schatzberg
Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsBiological bases of depressive disorders;, glucocorticoid/dopamine interactions in delusional depression;, pharmacologic treatment of depressive disorders.
-
David Scheinker
Clinical Professor, Pediatrics - Endocrinology
Clinical Professor, MedicineBioDavid Scheinker is the Executive Director of Systems Design and Collaborative Research at the Stanford Lucile Packard Children's Hospital. He is the Founder and Director of SURF Stanford Medicine, a group that brings together students and faculty from the university with physicians, nurses, and administrators from the hospitals. SURF has implemented and published dozens of projects demonstrating improvements to the quality and efficiency of care. His areas of focus include clinical care delivery, technical improvements to hospital operations, sensor-based and algorithm-enabled telemedicine, and the socioeconomic factors that shape healthcare cost and quality.
Before coming to Stanford, he was a Joint Research Fellow at The MIT Sloan School of Management and Massachusetts General Hospital. He received a PhD in theoretical math from The University of California San Diego under Jim Agler. He advises Carta Healthcare, a healthcare analytics company started by former students. -
Stephen Schendel
Professor of Surgery (Plastic and Reconstructive Surgery) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsSurgical correction and the study of growth and development of craniomaxillofacial anomalies and deformities.
1. Histochemical Analysis of Facial Muscles.
2. Cranial Sutural Manipulation.
3. Stability of Mandibular and Maxillary Surgery.
4. Growth Factors in Infant Cranial Sutures.
5. Virtual Surgery.
6. 3-D Biocomputation4. Osteodistraction -
Kimberly Schertzer
Clinical Associate Professor, Emergency Medicine
Current Research and Scholarly InterestsInterests include simulation for procedural training, faculty development, and teamwork.
-
Erika Schillinger
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy passion is clinical skills education: the patient's experience of health and healthcare, doctor-patient communication, professionalism and physical exam. I am focused on curriculum design and innovation, having helped develop the Continuity of Care Clerkship, the clinical skills curriculum in Practice of Medicine, the Family Medicine core clerkship, outpatient faculty development modules and the SHIELD course (Stanford Healthcare Innovations and Experiential Learning Directive).
-
Michel Schimpf
Graduate, Medicine, Dermatology
BioMichel Schimpf is a PhD candidate affiliated with Stanford and Cambridge, working at the intersection of AI and Psychology. His research investigates how large language model–based systems can be used to scale behavior change interventions, with a focus on goal setting, dietary behavior, and emotional well-being. Michel has a background in Computer Science, completing his Bachelor's at TUM with a minor in Psychology at LMU Munich. He previously worked on alignment research at Mistral. Alongside his academic work, he co-founded wahl.chat, a chatbot for political education that reached over 250,000 users, and Techdalo, a nonprofit teaching programming skills to Colombian students.
-
Noelle Schlenk
Contingent ADM 1, Pediatrics - Rheumatology
BioNoelle is a Research Data Analyst for the Immune Behavioral Health Clinic / research team. She applies her expertise in statistics and bioinformatics to investigate genetic components of Pediatric Acute-onset Neuropsychiatric Syndrome (PANS).
Noelle holds a master's degree in Ecology & Evolutionary Biology from the University of Kansas. -
Adam Craig Schlifke
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Schlifke is a board-certified anesthesiologist and former medical director with fundamental business training highly motivated to improve healthcare delivery in the US through technology. He enjoys working in entrepreneurial environments that are focused on designing innovative solutions that are well integrated into the healthcare workflow. Dr. Schlifke loves to "disrupt" healthcare delivery with technology-enabled services.
-
Gavin Schlissel
Assistant Professor of Chemical and Systems Biology
Current Research and Scholarly InterestsI am interested in understanding how interactions between signaling proteins and the extracellular matrix affect the function and evolution of animal signaling networks. My work touches on many themes in animal biology, including developmental biology, immunology, aging and metabolism.
-
Mariana Schmajuk
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioMariana Schmajuk received her medical school education at Boston University School of Medicine in 2012. She completed her General Adult Psychiatry Residency program Mount Sinai School of Medicine in New York in 2016, serving as Chief Resident with a focus on the early transition from medical school to residency. She went on to complete her Consult-Liaison fellowship at New York-Presbyterian Hospital Columbia University Medical Center in 2017.
Dr. Schmajuk joined Stanford University CLP team in 2017. She is a primary member of the emergency medicine consultations, working collaboratively with a nurse practioner, social worker and residents. Clinically, Dr. Schmajuk focuses on treating patients with terminal neurological disorders and oncological processes. Dr. Schmajuk is the director of the Psychosomatic Continuity clinic where residents and fellows are able to assess and longitudinally treat patients with psychiatric sequela in the context of complex medical illness. She has a particular interest in brief psychotherapeutic interventions. She enjoys teaching medical students about CL psychiatry and interviewing skills. At present, Dr. Schmajuk is using techniques of applied improvisation to educate psychiatry residents and others about the building blocks of communication. She also is an active member of the bioethics committee. -
Peter Schmidt
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioPete Schmidt, MD, MSc is an Assistant Clinical Professor in the Department of Anesthesiology, Perioperative, and Pain Medicine, Division of Pain Medicine at Stanford University School of Medicine, where he conceptualized and launched the Stanford Cancer Pain program. He provides comprehensive and individualized care for patients with cancer-related pain, including patients who are suffering from the effects of cancer treatment. His clinical expertise also includes ultrasound-guided nerve blocks, perioperative pain management, and safe medication tapering after definitive cancer treatment. He is board-certified in Anesthesiology, Pain Medicine, and Addiction Medicine.
Dr. Schmidt's research interests are in clinical trials, drug development, and novel regulatory endpoints. He has designed and led over a dozen clinical trials in the fields of pain management, neurology, infectious diseases, and rare diseases. Dr. Schmidt has published his research findings in several high-impact journals, including Science: Translational Medicine and the New England Journal of Medicine. He is also the author of several book chapters on pain management and perioperative management.
